Mechanism of canine coronary artery relaxation by monensin.
D000628:Aminophylline / Q000494:pharmacology; D000818:Animals; D003331:Coronary Vessels / Q000187:drug effects / Q000294:innervation / Q000502:physiology*; D003714:Denervation; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D005260:Female; D005663:Furans / Q000494:pharmacology*; D007213:Indomethacin / Q000494:pharmacology; D007700:Kinetics; D008297:Male; D008985:Monensin / Q000494:pharmacology*; D009119:Muscle Contraction / Q000187:drug effects*; D009126:Muscle Relaxation / Q000187:drug effects*; D009131:Muscle, Smooth, Vascular / Q000187:drug effects / Q000502:physiology; D010042:Ouabain / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D000254:Sodium-Potassium-Exchanging ATPase / Q000378:metabolism
D005663:Furans; D000628:Aminophylline; D010042:Ouabain; D008985:Monensin; D011433:Propranolol; D000254:Sodium-Potassium-Exchanging ATPase; D007213:Indomethacin